Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RITODRINE vs RIVASTIGMINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RITODRINE vs RIVASTIGMINE: Safety Overview

Metric RITODRINE RIVASTIGMINE
Total FAERS Reports 256 9,123
Deaths Reported 7 2,232
Death Rate 2.7% 24.5%
Hospitalizations 90 2,716
Average Patient Age 33.9 yrs 80.0 yrs
% Female Patients 85.7% 59.5%
FDA Approval Date Approved Prior to Jan 1, 1982 Apr 21, 2000
Manufacturer N/A Novartis Pharmaceuticals Corporation
Route N/A TRANSDERMAL
Marketing Status Discontinued Discontinued